# Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM

> **NCT06205823** · — · UNKNOWN · sponsor: **Seoul St. Mary's Hospital** · enrollment: 1600 (estimated)

## Conditions studied

- Myeloma Multiple

## Interventions

- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT06205823
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-25
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2024-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06205823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06205823, "Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06205823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*